Breaking News
October 18, 2018 - 5 Strength-Training Mistakes to Avoid
October 18, 2018 - Immune system’s balancing act keeps bowel disease in check
October 18, 2018 - Anti-inflammatory drug effective for treating lymphedema symptoms | News Center
October 18, 2018 - Keeping Your Voice Young
October 18, 2018 - One-time universal screening recommended to tackle increase in hepatitis C
October 18, 2018 - Researchers to develop new stem cell-based strategies for treating vision disorders
October 18, 2018 - Detecting epigenetic signature may help people stay ahead of inflammatory bowel disease
October 18, 2018 - Understanding AFib: Slowing down the dancing heart
October 18, 2018 - Using NMR to Reduce Fraud
October 18, 2018 - New automated model identifies dense breast tissue in mammograms
October 18, 2018 - Mysterious polio-like illness baffles medical experts while frightening parents
October 18, 2018 - Cases of Acute Flaccid Myelitis on the rise across U.S.
October 18, 2018 - Dietary fiber reduces brain inflammation during aging
October 18, 2018 - New tool could help prioritize recovery efforts for the poorest hit by natural disasters
October 18, 2018 - Hundreds of dietary supplements shown to contain unapproved drugs
October 18, 2018 - Active Pharmaceuticals ID’d in >700 Dietary Supplements
October 18, 2018 - Cell death protein also damps inflammation
October 18, 2018 - Health Highlights: Oct. 15, 2018
October 18, 2018 - Largest study of ‘post-treatment controllers’ reveals clues about HIV remission
October 18, 2018 - Bad Blood in Silicon Valley: A conversation with John Carreyrou
October 18, 2018 - ANTRUK’s Annual Lecture sends out message on shortage of funds for antibiotic research
October 18, 2018 - NAM special publication outlines steps to ensure interoperability of health care systems
October 18, 2018 - Novel method uses just a drop of blood to monitor effect of lung cancer therapy
October 18, 2018 - New blood test could spare cancer patients from unnecessary chemotherapy
October 18, 2018 - Training young researchers to work with data volumes arising in the health sector
October 18, 2018 - New Metrohm IC method is reliable and convenient to use for zinc oxide assay
October 18, 2018 - Global AIDS, TB fight needs more money: health fund
October 18, 2018 - Understanding the forces that cause sports concussions
October 18, 2018 - Research points to new target for treating periodontitis
October 18, 2018 - New tool improves assessment of postpartum depression symptoms
October 18, 2018 - From Biopsy to Diagnosis
October 18, 2018 - Sexual harassment and assault linked to worse physical/mental health among midlife women
October 18, 2018 - Stumped by medical school? A Q&A with a learning specialist
October 18, 2018 - Report predicts life expectancy in 2040, Spain comes out on top
October 18, 2018 - Self-lubricating condoms may help raise condom usage
October 18, 2018 - Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation
October 18, 2018 - Study finds changes in antiepileptic drug metabolism during different trimesters of pregnancy
October 18, 2018 - Autonomic nervous system directly controls stem cell proliferation, study shows
October 18, 2018 - FDA Approves Talzenna (talazoparib) for gBRCAm HER2-Negative Locally Advanced or Metastatic Breast Cancer
October 18, 2018 - Sleeping Beauty technique helps identify genes responsible for NAFLD-associated liver cancer
October 18, 2018 - Many U.S. adults confused about primary care, study shows
October 18, 2018 - UC researcher focuses on light-mediated therapies to target breast cancer
October 18, 2018 - With philanthropic gifts, Stanford poised to make major advances in neurosciences | News Center
October 18, 2018 - Mice study shows antibiotics are not always necessary to cure sepsis
October 18, 2018 - Researchers discover why heart contractions are weaker in individuals with HCM
October 18, 2018 - Participation in organized sport during childhood may have long-term skeletal benefits
October 18, 2018 - Probiotic/antibiotic combination could eradicate drug-resistant bacteria
October 17, 2018 - More Socioeconomic Challenges for Hispanic Women With HIV
October 17, 2018 - 49,XXXXY syndrome – Genetics Home Reference
October 17, 2018 - Scientists uncover possible new causes of Tourette syndrome
October 17, 2018 - Girl undergoes unusual heart surgery after compassionate-use exemption | News Center
October 17, 2018 - Health Issues That Are Sometimes Mistaken for Gluten Sensitivity
October 17, 2018 - Elective induction of labor at 39 weeks may be beneficial option for women and their babies
October 17, 2018 - New smart watch algorithms can accurately monitor wearers’ sleep patterns
October 17, 2018 - Researchers demonstrate epigenetic memory transmission via sperm
October 17, 2018 - FDA, DHS announce memorandum of agreement to address cybersecurity in medical devices
October 17, 2018 - Health Tip: Know the Risks of Chicken Pox
October 17, 2018 - Immunotherapy effective against hereditary melanoma
October 17, 2018 - Researchers reveal new mechanism for how animal cells stay intact | News Center
October 17, 2018 - Alzheimer's Goes Under the Cryo-Electron Microscope
October 17, 2018 - Medicare for all? CMS chief warns program has enough problems already
October 17, 2018 - Metrohm Raman introduces Mira P handheld Raman system
October 17, 2018 - Expanding the knowledge about hippocampus to better understand cognitive deficits in MS
October 17, 2018 - Study of Nigerian breast cancer patients reveals prevalence of aggressive molecular features
October 17, 2018 - Many healthy children may have metabolic risk factors, finds study
October 17, 2018 - A new antibiotic could be a better, faster treatment for tuberculosis
October 17, 2018 - “I will not become a Robot Doctor”: A medical student vows to practice compassion
October 17, 2018 - Study findings may explain sporadic outbreaks of C. difficile infections in hospitals
October 17, 2018 - Purdue researchers develop new chemical process to find better drug ‘fits’ for patients
October 17, 2018 - Yale researchers develop way to attack RNA with small-molecule drugs
October 17, 2018 - New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug
October 17, 2018 - Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application and Pursue Full Approval for Givosiran
October 17, 2018 - Nine cases of polio-like illness suspected in children in illinois
October 17, 2018 - Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries
October 17, 2018 - Patients once thought incurable can benefit from high-dose radiation therapy
October 17, 2018 - Researchers awarded grant to advance testing of experimental heroin vaccine
October 17, 2018 - Researchers examine SSRI use during pregnancy and major gestational malformations
October 17, 2018 - FDA grants Rare Pediatric Disease Designation for Immusoft’s Iduronicrin genleukocel-T
October 17, 2018 - Reliable Respiratory announces acquisition of Attleboro Area Medical Equipment
October 17, 2018 - Study reveals link between childhood abuse and higher arthritis risk in adulthood
Number of seamless clinical trials in oncology has risen recently

Number of seamless clinical trials in oncology has risen recently

image_pdfDownload PDFimage_print

The number of early-phase trials in oncology that adopted a seamless approach, as opposed to a traditional trial approach with defined phase I, II, and III plans, is rising, with data from the majority of them presented after 2014, according to a study presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 26-30.

“Seamless trials are combined studies where, instead of conducting the conventional phases I, II, and III, the trial adapts and expands based on the results of interim data,” said Pedro Barata, MD, MSc, Experimental Therapeutics Fellow at the Cleveland Clinic in Ohio. “First-in-human phase I studies adopting a seamless approach have the flexibility to expand rapidly with multiple cohorts enrolling hundreds of patients in large expansion cohorts, which tends to save time in the drug development process.”

The development of more effective therapies and improved patient selection with biomarker discovery in the last decade has led to calls to expedite the drug development process, explained Barata. Consequently, there has been an expansion of creative trial designs that could provide preliminary signals of efficacy and sufficient data to make the tested therapeutics eligible for early approval.

Although seamless design–based early-phase trials are expanding, their prevalence, clinical design, and characteristics are unclear, Barata noted. He and his collaborators conducted a multi-institutional study to evaluate these factors and their success, by measuring the number of drugs tested in these trials included in the expedited programs run by the U.S. Food and Drug Administration (FDA).

The researchers reviewed all clinical trial abstracts presented at the American Society of Clinical Oncology annual meetings between 2010 and 2017. Seamless trials were defined as any early- phase studies that enrolled 100 or more patients. Of the 1,786 phase I/II trials identified, 3 percent (51 trials) were seamless trials, but accounted for 15 percent of all the patients enrolled. Seamless trials had up to 13 expansion cohorts and data from 65 percent of them were presented after 2014.

Overall, 50 investigational new drugs were tested in early studies using a seamless approach, which included targeted therapies, immunotherapies, antibody-drug conjugates, and chemotherapies, tested as single agents or in combinations.

Data showed that the FDA had granted accelerated approval for eight therapeutics (16 percent) and a priority review for a ninth agent tested in seamless trials. “It is estimated that only 5 percent of oncology drugs that enter human testing ultimately receive FDA approval, therefore, our findings seem to confirm the higher success rate of the drugs studied with the seamless approach,” Barata said.

The researchers also found that of the 29 studies published from the 51 seamless trials, 69 percent of them did not have a plan for statistical analysis to calculate the sample sizes of the expansion cohorts.

“Whenever a pre-planned statistical plan is missing, the value of the data is limited, being simply descriptive and demanding further validation,” explained Barata. “The numerous, nonrandomized cohorts in each trial and modifications to the study design with multiple amendments put these studies at a higher rate for false-positive or false-negative errors compared with later-phase trials, thus affecting the validity and interpretation of the data.”

While seamless studies offer rapid access to anticancer drugs via accelerated FDA approval, Barata cautioned that concerns, such as potential exposure of patients and drug developers to avoidable risks due to lack of safety monitoring system, communication challenges between pharmaceutical companies, investigators, and regulators regarding frequent protocol modifications, and potential limitations with maintenance of data quality and statistical integrity with these designs need to be addressed in order to improve the quality of this approach and outcomes.

Limitations of the study include its retrospective nature, the inclusion of studies from a single national meeting, and limited access to trial information (meeting abstracts) and not the complete trial protocols.


Explore further:
How do drugs get from the point of discovery to the pharmacy shelf?

Provided by:
American Association for Cancer Research

Tagged with:

About author

Related Articles